Report Detail
Global Urokinase Market Growth 2019-2024
- RnM3002107 |
- 22 February, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase industry has a rather high concentration. The major manufacturers are concentrated in China, such as NDPharm, Wanhua Biochem, Jiangxi Haoran Bio-Pharma and Jiangsu Aidea Pharmaceutica. At present, NDPharm is the world leader, holding 61.93% production market share in 2016.
In 2016, the global Urokinase consumption market is led by China and China is the largest region consumption market, accounting for about 18.58% of global consumption of Urokinase.
Urokinase downstream is wide and recently Urokinase has acquired increasing significance in various fields of Hospital, Clinic and others. Globally, the Urokinase market is mainly driven by growing demand for Hospital. Hospital accounts for nearly 78.59% of total downstream consumption of Urokinase in global.
According to this study, over the next five years the Urokinase market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Urokinase business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Urokinase market by product type, application, key manufacturers and key regions and countries.
This study considers the Urokinase value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Urokinase Powder
Urokinase Solution
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
NDPharm
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Urokinase consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Urokinase market by identifying its various subsegments.
Focuses on the key global Urokinase manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Urokinase with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Urokinase submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Urokinase Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Urokinase Consumption 2014-2024
- 2.1.2 Urokinase Consumption CAGR by Region
- 2.2 Urokinase Segment by Type
- 2.2.1 Urokinase Powder
- 2.2.2 Urokinase Solution
- 2.3 Urokinase Consumption by Type
- 2.3.1 Global Urokinase Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Urokinase Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Urokinase Sale Price by Type (2014-2019)
- 2.4 Urokinase Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Others
- 2.5 Urokinase Consumption by Application
- 2.5.1 Global Urokinase Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Urokinase Value and Market Share by Application (2014-2019)
- 2.5.3 Global Urokinase Sale Price by Application (2014-2019)
3 Global Urokinase by Players
- 3.1 Global Urokinase Sales Market Share by Players
- 3.1.1 Global Urokinase Sales by Players (2017-2019)
- 3.1.2 Global Urokinase Sales Market Share by Players (2017-2019)
- 3.2 Global Urokinase Revenue Market Share by Players
- 3.2.1 Global Urokinase Revenue by Players (2017-2019)
- 3.2.2 Global Urokinase Revenue Market Share by Players (2017-2019)
- 3.3 Global Urokinase Sale Price by Players
- 3.4 Global Urokinase Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Urokinase Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Urokinase Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Urokinase by Regions
- 4.1 Urokinase by Regions
- 4.1.1 Global Urokinase Consumption by Regions
- 4.1.2 Global Urokinase Value by Regions
- 4.2 Americas Urokinase Consumption Growth
- 4.3 APAC Urokinase Consumption Growth
- 4.4 Europe Urokinase Consumption Growth
- 4.5 Middle East & Africa Urokinase Consumption Growth
5 Americas
- 5.1 Americas Urokinase Consumption by Countries
- 5.1.1 Americas Urokinase Consumption by Countries (2014-2019)
- 5.1.2 Americas Urokinase Value by Countries (2014-2019)
- 5.2 Americas Urokinase Consumption by Type
- 5.3 Americas Urokinase Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Urokinase Consumption by Countries
- 6.1.1 APAC Urokinase Consumption by Countries (2014-2019)
- 6.1.2 APAC Urokinase Value by Countries (2014-2019)
- 6.2 APAC Urokinase Consumption by Type
- 6.3 APAC Urokinase Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Urokinase by Countries
- 7.1.1 Europe Urokinase Consumption by Countries (2014-2019)
- 7.1.2 Europe Urokinase Value by Countries (2014-2019)
- 7.2 Europe Urokinase Consumption by Type
- 7.3 Europe Urokinase Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Urokinase by Countries
- 8.1.1 Middle East & Africa Urokinase Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Urokinase Value by Countries (2014-2019)
- 8.2 Middle East & Africa Urokinase Consumption by Type
- 8.3 Middle East & Africa Urokinase Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Urokinase Distributors
- 10.3 Urokinase Customer
11 Global Urokinase Market Forecast
- 11.1 Global Urokinase Consumption Forecast (2019-2024)
- 11.2 Global Urokinase Forecast by Regions
- 11.2.1 Global Urokinase Forecast by Regions (2019-2024)
- 11.2.2 Global Urokinase Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Urokinase Forecast by Type
- 11.8 Global Urokinase Forecast by Application
12 Key Players Analysis
- 12.1 NDPharm
- 12.1.1 Company Details
- 12.1.2 Urokinase Product Offered
- 12.1.3 NDPharm Urokinase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 NDPharm News
- 12.2 Wanhua Biochem
- 12.2.1 Company Details
- 12.2.2 Urokinase Product Offered
- 12.2.3 Wanhua Biochem Urokinase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Wanhua Biochem News
- 12.3 Jiangxi Haoran Bio-Pharma
- 12.3.1 Company Details
- 12.3.2 Urokinase Product Offered
- 12.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Jiangxi Haoran Bio-Pharma News
- 12.4 Jiangsu Aidea Pharmaceutical
- 12.4.1 Company Details
- 12.4.2 Urokinase Product Offered
- 12.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Jiangsu Aidea Pharmaceutical News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Urokinase . Industry analysis & Market Report on Urokinase is a syndicated market report, published as Global Urokinase Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Urokinase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
